<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p223" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_223{left:35px;bottom:24px;letter-spacing:-0.34px;word-spacing:0.13px;}
#t2_223{left:306px;bottom:30px;}
#t3_223{left:313px;bottom:24px;letter-spacing:0.16px;}
#t4_223{left:346px;bottom:30px;}
#t5_223{left:351px;bottom:24px;letter-spacing:-0.16px;word-spacing:-0.22px;}
#t6_223{left:517px;bottom:30px;}
#t7_223{left:524px;bottom:24px;letter-spacing:-0.28px;word-spacing:-0.09px;}
#t8_223{left:288px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.55px;}
#t9_223{left:288px;bottom:829px;letter-spacing:0.27px;word-spacing:-0.69px;}
#ta_223{left:1115px;bottom:27px;letter-spacing:0.23px;}
#tb_223{left:35px;bottom:777px;letter-spacing:0.08px;word-spacing:0.1px;}
#tc_223{left:35px;bottom:757px;letter-spacing:0.16px;}
#td_223{left:396px;bottom:757px;}
#te_223{left:35px;bottom:722px;letter-spacing:0.14px;word-spacing:0.05px;}
#tf_223{left:35px;bottom:702px;letter-spacing:0.12px;word-spacing:-0.07px;}
#tg_223{left:35px;bottom:683px;letter-spacing:0.05px;word-spacing:-0.76px;}
#th_223{left:35px;bottom:665px;letter-spacing:0.06px;word-spacing:-1.1px;}
#ti_223{left:35px;bottom:645px;letter-spacing:-0.38px;}
#tj_223{left:59px;bottom:645px;letter-spacing:0.16px;}
#tk_223{left:409px;bottom:645px;}
#tl_223{left:35px;bottom:608px;letter-spacing:0.12px;word-spacing:0.07px;}
#tm_223{left:35px;bottom:589px;letter-spacing:0.03px;word-spacing:0.16px;}
#tn_223{left:35px;bottom:570px;letter-spacing:0.11px;word-spacing:0.08px;}
#to_223{left:35px;bottom:551px;letter-spacing:0.11px;word-spacing:0.08px;}
#tp_223{left:35px;bottom:531px;letter-spacing:0.16px;}
#tq_223{left:386px;bottom:531px;}
#tr_223{left:35px;bottom:495px;letter-spacing:0.03px;word-spacing:0.16px;}
#ts_223{left:35px;bottom:476px;letter-spacing:0.09px;word-spacing:-0.42px;}
#tt_223{left:35px;bottom:457px;letter-spacing:0.12px;word-spacing:0.07px;}
#tu_223{left:35px;bottom:437px;letter-spacing:0.16px;}
#tv_223{left:386px;bottom:437px;}
#tw_223{left:35px;bottom:401px;letter-spacing:0.04px;word-spacing:0.15px;}
#tx_223{left:35px;bottom:382px;letter-spacing:0.08px;word-spacing:0.11px;}
#ty_223{left:35px;bottom:363px;letter-spacing:0.12px;word-spacing:0.07px;}
#tz_223{left:35px;bottom:343px;letter-spacing:-0.23px;word-spacing:1.63px;}
#t10_223{left:132px;bottom:343px;letter-spacing:0.16px;}
#t11_223{left:493px;bottom:343px;}
#t12_223{left:35px;bottom:306px;letter-spacing:0.15px;word-spacing:-0.45px;}
#t13_223{left:35px;bottom:288px;letter-spacing:0.07px;word-spacing:0.11px;}
#t14_223{left:35px;bottom:269px;letter-spacing:0.12px;word-spacing:0.07px;}
#t15_223{left:35px;bottom:249px;letter-spacing:0.16px;}
#t16_223{left:396px;bottom:249px;}
#t17_223{left:35px;bottom:212px;letter-spacing:0.11px;word-spacing:0.08px;}
#t18_223{left:35px;bottom:194px;letter-spacing:0.11px;word-spacing:0.08px;}
#t19_223{left:35px;bottom:174px;letter-spacing:0.1px;word-spacing:0.08px;}
#t1a_223{left:35px;bottom:155px;letter-spacing:0.16px;}
#t1b_223{left:396px;bottom:155px;}
#t1c_223{left:35px;bottom:118px;letter-spacing:0.11px;word-spacing:0.08px;}
#t1d_223{left:35px;bottom:100px;letter-spacing:0.11px;word-spacing:0.07px;}
#t1e_223{left:35px;bottom:80px;letter-spacing:0.16px;word-spacing:0.02px;}
#t1f_223{left:618px;bottom:777px;letter-spacing:0.07px;word-spacing:0.11px;}
#t1g_223{left:618px;bottom:757px;letter-spacing:0.16px;}
#t1h_223{left:979px;bottom:757px;}
#t1i_223{left:618px;bottom:722px;letter-spacing:0.06px;word-spacing:0.13px;}
#t1j_223{left:618px;bottom:702px;letter-spacing:0.03px;word-spacing:0.16px;}
#t1k_223{left:618px;bottom:683px;letter-spacing:0.02px;word-spacing:-0.46px;}
#t1l_223{left:618px;bottom:663px;letter-spacing:-0.23px;word-spacing:1.63px;}
#t1m_223{left:715px;bottom:663px;letter-spacing:0.16px;}
#t1n_223{left:1076px;bottom:663px;}
#t1o_223{left:618px;bottom:628px;letter-spacing:0.1px;word-spacing:0.09px;}
#t1p_223{left:618px;bottom:608px;letter-spacing:0.06px;word-spacing:0.12px;}
#t1q_223{left:618px;bottom:589px;letter-spacing:0.08px;word-spacing:0.1px;}
#t1r_223{left:618px;bottom:570px;letter-spacing:0.12px;word-spacing:0.06px;}
#t1s_223{left:618px;bottom:551px;letter-spacing:0.08px;word-spacing:0.1px;}
#t1t_223{left:618px;bottom:531px;letter-spacing:0.16px;}
#t1u_223{left:979px;bottom:531px;}
#t1v_223{left:618px;bottom:495px;letter-spacing:0.14px;word-spacing:0.05px;}
#t1w_223{left:618px;bottom:476px;letter-spacing:0.01px;word-spacing:-0.75px;}
#t1x_223{left:618px;bottom:457px;letter-spacing:0.1px;word-spacing:0.09px;}
#t1y_223{left:618px;bottom:437px;letter-spacing:0.13px;word-spacing:0.06px;}
#t1z_223{left:618px;bottom:418px;letter-spacing:-0.23px;word-spacing:1.63px;}
#t20_223{left:715px;bottom:418px;letter-spacing:0.16px;}
#t21_223{left:1076px;bottom:418px;}
#t22_223{left:618px;bottom:382px;letter-spacing:0.01px;word-spacing:0.17px;}
#t23_223{left:618px;bottom:363px;letter-spacing:0.09px;word-spacing:0.1px;}
#t24_223{left:618px;bottom:343px;letter-spacing:0.13px;word-spacing:0.06px;}
#t25_223{left:618px;bottom:324px;letter-spacing:0.16px;}
#t26_223{left:979px;bottom:324px;}
#t27_223{left:618px;bottom:288px;letter-spacing:0.04px;word-spacing:0.15px;}
#t28_223{left:618px;bottom:269px;letter-spacing:0.09px;word-spacing:-0.28px;}
#t29_223{left:618px;bottom:249px;letter-spacing:0.13px;word-spacing:0.06px;}
#t2a_223{left:618px;bottom:229px;letter-spacing:0.16px;}
#t2b_223{left:979px;bottom:229px;}
#t2c_223{left:618px;bottom:194px;letter-spacing:0.09px;word-spacing:0.1px;}
#t2d_223{left:618px;bottom:174px;letter-spacing:0.1px;word-spacing:0.09px;}
#t2e_223{left:618px;bottom:155px;letter-spacing:0.12px;word-spacing:0.07px;}
#t2f_223{left:618px;bottom:135px;letter-spacing:0.06px;word-spacing:0.13px;}
#t2g_223{left:618px;bottom:116px;letter-spacing:0.16px;}
#t2h_223{left:988px;bottom:116px;}
#t2i_223{left:618px;bottom:80px;letter-spacing:0.02px;word-spacing:-0.56px;}
#t2j_223{left:618px;bottom:61px;letter-spacing:0.07px;word-spacing:-1.12px;}
#t2k_223{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_223{font-size:10px;font-family:ArialMT_5tg;color:#000;}
.s1_223{font-size:6px;font-family:ArialMT_5tg;color:#000;}
.s2_223{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_223{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_223{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s5_223{font-size:17px;font-family:ArialMT_5tg;color:#005B99;}
.s6_223{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts223" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg223Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg223" style="-webkit-user-select: none;"><object width="1210" height="935" data="223/223.svg" type="image/svg+xml" id="pdf223" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_223" class="t s0_223">Version 4.2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_223" class="t s1_223">© </span>
<span id="t3_223" class="t s0_223">(NCCN </span>
<span id="t4_223" class="t s1_223">© </span>
<span id="t5_223" class="t s0_223">), All rights reserved. NCCN Guidelines </span>
<span id="t6_223" class="t s1_223">® </span>
<span id="t7_223" class="t s0_223">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_223" class="t s2_223">NCCN Guidelines Version 4.2024 </span>
<span id="t9_223" class="t s2_223">Head and Neck Cancers </span>
<span id="ta_223" class="t s3_223">MS-82 </span>
<span id="tb_223" class="t s4_223">2012;27:467-474. Available at: </span>
<span id="tc_223" class="t s5_223">http://www.ncbi.nlm.nih.gov/pubmed/22020564</span><span id="td_223" class="t s4_223">. </span>
<span id="te_223" class="t s4_223">290. Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in </span>
<span id="tf_223" class="t s4_223">pyriform sinus cancer: preliminary results of a European Organization for </span>
<span id="tg_223" class="t s4_223">Research and Treatment of Cancer phase III trial. EORTC Head and Neck </span>
<span id="th_223" class="t s4_223">Cancer Cooperative Group. J Natl Cancer Inst 1996;88:890-899. Available </span>
<span id="ti_223" class="t s4_223">at: </span><span id="tj_223" class="t s5_223">http://www.ncbi.nlm.nih.gov/pubmed/8656441</span><span id="tk_223" class="t s4_223">. </span>
<span id="tl_223" class="t s4_223">291. Induction chemotherapy plus radiation compared with surgery plus </span>
<span id="tm_223" class="t s4_223">radiation in patients with advanced laryngeal cancer. The Department of </span>
<span id="tn_223" class="t s4_223">Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med </span>
<span id="to_223" class="t s4_223">1991;324:1685-1690. Available at: </span>
<span id="tp_223" class="t s5_223">http://www.ncbi.nlm.nih.gov/pubmed/2034244</span><span id="tq_223" class="t s4_223">. </span>
<span id="tr_223" class="t s4_223">292. McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival: </span>
<span id="ts_223" class="t s4_223">tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J </span>
<span id="tt_223" class="t s4_223">Med 1981;305:982-987. Available at: </span>
<span id="tu_223" class="t s5_223">http://www.ncbi.nlm.nih.gov/pubmed/7278922</span><span id="tv_223" class="t s4_223">. </span>
<span id="tw_223" class="t s4_223">293. Pignon J-P, le Maitre A, Maillard E, Bourhis J. Meta-analysis of </span>
<span id="tx_223" class="t s4_223">chemotherapy in head and neck cancer (MACH-NC): an update on 93 </span>
<span id="ty_223" class="t s4_223">randomised trials and 17,346 patients. Radiother Oncol 2009;92:4-14. </span>
<span id="tz_223" class="t s4_223">Available at: </span><span id="t10_223" class="t s5_223">http://www.ncbi.nlm.nih.gov/pubmed/19446902</span><span id="t11_223" class="t s4_223">. </span>
<span id="t12_223" class="t s4_223">294. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy </span>
<span id="t13_223" class="t s4_223">and radiotherapy for organ preservation in advanced laryngeal cancer. N </span>
<span id="t14_223" class="t s4_223">Engl J Med 2003;349:2091-2098. Available at: </span>
<span id="t15_223" class="t s5_223">http://www.ncbi.nlm.nih.gov/pubmed/14645636</span><span id="t16_223" class="t s4_223">. </span>
<span id="t17_223" class="t s4_223">295. Hanna GJ, Haddad RI, Lorch JH. Induction chemotherapy for </span>
<span id="t18_223" class="t s4_223">locoregionally advanced head and neck cancer: past, present, future? </span>
<span id="t19_223" class="t s4_223">Oncologist 2013;18:288-293. Available at: </span>
<span id="t1a_223" class="t s5_223">http://www.ncbi.nlm.nih.gov/pubmed/23442306</span><span id="t1b_223" class="t s4_223">. </span>
<span id="t1c_223" class="t s4_223">296. Argiris A, Haraf DJ, Kies MS, Vokes EE. Intensive concurrent </span>
<span id="t1d_223" class="t s4_223">chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and </span>
<span id="t1e_223" class="t s4_223">hydroxyurea-based regimens: reversing a pattern of failure. Oncologist </span>
<span id="t1f_223" class="t s4_223">2003;8:350-360. Available at: </span>
<span id="t1g_223" class="t s5_223">http://www.ncbi.nlm.nih.gov/pubmed/12897332</span><span id="t1h_223" class="t s4_223">. </span>
<span id="t1i_223" class="t s4_223">297. Machtay M, Moughan J, Farach A, et al. Hypopharyngeal dose is </span>
<span id="t1j_223" class="t s4_223">associated with severe late toxicity in locally advanced head-and-neck </span>
<span id="t1k_223" class="t s4_223">cancer: an RTOG analysis. Int J Radiat Oncol Biol Phys 2012;84:983-989. </span>
<span id="t1l_223" class="t s4_223">Available at: </span><span id="t1m_223" class="t s5_223">http://www.ncbi.nlm.nih.gov/pubmed/23078898</span><span id="t1n_223" class="t s4_223">. </span>
<span id="t1o_223" class="t s4_223">298. Lorch JH, Goloubeva O, Haddad RI, et al. Induction chemotherapy </span>
<span id="t1p_223" class="t s4_223">with cisplatin and fluorouracil alone or in combination with docetaxel in </span>
<span id="t1q_223" class="t s4_223">locally advanced squamous-cell cancer of the head and neck: long-term </span>
<span id="t1r_223" class="t s4_223">results of the TAX 324 randomised phase 3 trial. Lancet Oncol </span>
<span id="t1s_223" class="t s4_223">2011;12:153-159. Available at: </span>
<span id="t1t_223" class="t s5_223">http://www.ncbi.nlm.nih.gov/pubmed/21233014</span><span id="t1u_223" class="t s4_223">. </span>
<span id="t1v_223" class="t s4_223">299. Hitt R, Lopez-Pousa A, Martinez-Trufero J, et al. Phase III study </span>
<span id="t1w_223" class="t s4_223">comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil </span>
<span id="t1x_223" class="t s4_223">induction chemotherapy followed by chemoradiotherapy in locally </span>
<span id="t1y_223" class="t s4_223">advanced head and neck cancer. J Clin Oncol 2005;23:8636-8645. </span>
<span id="t1z_223" class="t s4_223">Available at: </span><span id="t20_223" class="t s5_223">http://www.ncbi.nlm.nih.gov/pubmed/16275937</span><span id="t21_223" class="t s4_223">. </span>
<span id="t22_223" class="t s4_223">300. Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and </span>
<span id="t23_223" class="t s4_223">fluorouracil alone or with docetaxel in head and neck cancer. N Engl J </span>
<span id="t24_223" class="t s4_223">Med 2007;357:1705-1715. Available at: </span>
<span id="t25_223" class="t s5_223">http://www.ncbi.nlm.nih.gov/pubmed/17960013</span><span id="t26_223" class="t s4_223">. </span>
<span id="t27_223" class="t s4_223">301. Vermorken JB, Remenar E, van Herpen C, et al. Cisplatin, </span>
<span id="t28_223" class="t s4_223">fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl </span>
<span id="t29_223" class="t s4_223">J Med 2007;357:1695-1704. Available at: </span>
<span id="t2a_223" class="t s5_223">http://www.ncbi.nlm.nih.gov/pubmed/17960012</span><span id="t2b_223" class="t s4_223">. </span>
<span id="t2c_223" class="t s4_223">302. Janoray G, Pointreau Y, Garaud P, et al. Long-term results of a </span>
<span id="t2d_223" class="t s4_223">multicenter randomized phase III trial of induction chemotherapy with </span>
<span id="t2e_223" class="t s4_223">cisplatin, 5-fluorouracil, +/- docetaxel for larynx preservation. J Natl </span>
<span id="t2f_223" class="t s4_223">Cancer Inst 2016;108:djv368. Available at: </span>
<span id="t2g_223" class="t s5_223">https://www.ncbi.nlm.nih.gov/pubmed/26681800</span><span id="t2h_223" class="t s4_223">. </span>
<span id="t2i_223" class="t s4_223">303. Pointreau Y, Garaud P, Chapet S, et al. Randomized trial of induction </span>
<span id="t2j_223" class="t s4_223">chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for </span>
<span id="t2k_223" class="t s6_223">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
